E.R. Squibb & Sons, L.L.C.
24 drugs in NADAC|0 Generic,24 Brand
E.R. Squibb & Sons, L.L.C. lists 24 NDCs in the CMS NADAC file (0 generic, 24 brand), at an average NADAC of $177.84 per unit, with a week-over-week move of +0.0% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
24
0G / 24B
Avg Price / Unit
$177.8423
$2.32 – $1470.78
Avg 7d Change
+0.03%
Across 13 drugs with changes
7d Activity
of 24 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Frequently Asked Questions
How many drugs does E.R. Squibb & Sons, L.L.C. make?
E.R. Squibb & Sons, L.L.C. lists 24 NDCs in the CMS NADAC file — 0 generic and 24 brand products.
What is the average price of E.R. Squibb & Sons, L.L.C. drugs?
The average NADAC across E.R. Squibb & Sons, L.L.C.'s portfolio is $177.8423 per unit, ranging from $2.3230 to $1470.7787.
What types of drugs does E.R. Squibb & Sons, L.L.C. make?
E.R. Squibb & Sons, L.L.C. makes drugs across 9 FDA pharmacologic classes. The most common by NDC count are Corticosteroid (5), Factor Xa Inhibitor (5), Protease Inhibitor (3), Cholinergic Muscarinic Agonist (3), Cholinergic Muscarinic Antagonist (3).
Has E.R. Squibb & Sons, L.L.C. had any drug recalls?
No FDA enforcement recalls are matched to E.R. Squibb & Sons, L.L.C. in the openFDA feed.
How has E.R. Squibb & Sons, L.L.C.'s pricing changed recently?
Over the past 7 days, 6 E.R. Squibb & Sons, L.L.C. products rose and 7 fell, with a portfolio-wide average change of +0.0%.